← Leaderboards
Herbert P. Schweizer
Colorado State University-Fort Collins
$10,215,772
Attributed
$11,555,172
Total exposure
15
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–22$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$11,555,172 · 15
By mechanism
U54$6,074,626 · 5
R01$4,134,171 · 3
R21$1,175,625 · 3
R03$145,000 · 1
R13$25,750 · 3
Top collaborators
- Edward W Yu4 shared
Most similar at Colorado State University-Fort Collins
Same institution · by research overlap
- Scott A Summers$17,535,017
- F. Edward Dudek$11,979,993
- Brian David Foy$8,995,321
- Karolin Luger$13,659,427
- Dean C Crick$6,993,235
Others in their field
Top investigators on “Pathogen”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$343,790,695
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
- Jeffrey P Krischer · University Of South Florida$130,496,919
- Mark S Klempner · Tufts Medical Center$128,021,180
- Timothy Stedman · American Type Culture Collection$122,230,581
- Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai$99,962,183
Research focus
PathogenAntibioticsBacteriaResistanceBiodefenseInfectionBurkholderia PseudomalleiMelioidosisMutantGrowthProteinsDiagnosticMemberGram-Negative BacteriaAntimicrobial ResistanceFundingResistant StrainPseudomonas AeruginosaResearch PersonnelAntimicrobialNovel TherapeuticsBurkholderiaBioterrorismExhibits
Grant awards (38)
Emerging antibiotic resistance in Gram-negative pathogens$667,051
R01 · FY2022 · AI
Emerging antibiotic resistance in Gram-negative pathogens$667,051
R01 · FY2021 · AI
Emerging antibiotic resistance in Gram-negative pathogens$665,756
R01 · FY2020 · AI
Emerging antibiotic resistance in Gram-negative pathogens$678,943
R01 · FY2019 · AI
Membrane bound Burkholderia pseudomallei PenA beta-lactamase$190,625
R21 · FY2018 · AI · contact PI
Membrane bound Burkholderia pseudomallei PenA beta-lactamase$228,750
R21 · FY2017 · AI · contact PI
South Asian Melioidosis Congress 2017$3,750
R13 · FY2017 · AI · contact PI
World Melioidosis Congress 2016$7,000
R13 · FY2016 · AI · contact PI
Mechanisms of Ferritin-iron Acquisition and Burkholderia pseudomallei Infection.$183,221
R21 · FY2014 · AI · contact PI
Mechanisms of Ferritin-iron Acquisition and Burkholderia pseudomallei Infection.$35,937
R21 · FY2014 · AI · contact PI
Developmental Research Projects$564,925
U54 · FY2013 · AI · contact PI
Burkholderia pseudomallei antimicrobial resistance mechanisms$252,112
U54 · FY2013 · AI · contact PI
Mechanisms of Ferritin-iron Acquisition and Burkholderia pseudomallei Infection.$181,865
R21 · FY2013 · AI · contact PI
Developmental Research Projects$820,229
U54 · FY2012 · AI · contact PI
Burkholderia pseudomallei antimicrobial resistance mechanisms$256,314
U54 · FY2012 · AI · contact PI
Developmental Research Projects$554,350
U54 · FY2011 · AI · contact PI
Burkholderia pseudomallei antimicrobial resistance mechanisms$244,809
U54 · FY2011 · AI · contact PI
Developmental Research Projects$617,197
U54 · FY2010 · AI · contact PI
Burkholderia pseudomallei antimicrobial resistance mechanisms$277,259
U54 · FY2010 · AI · contact PI
World Melioidosis Congress 2010$15,000
R13 · FY2010 · AI · contact PI
Developmental Research Projects$534,888
U54 · FY2009 · AI · contact PI
Burkholderia pseudomallei antimicrobial resistance mechanisms$239,888
U54 · FY2009 · AI · contact PI
RMRCE Devlopmental Research Projects$574,411
U54 · FY2008 · AI · contact PI
Burkholderia ssp. Novel Therapeutic Approaches$259,863
U54 · FY2008 · AI · contact PI
Evaluation of Novel Meliodosis Therapeutics$156,794
U54 · FY2008 · AI · contact PI
Burkholderia ssp. Novel Therapeutic Approaches$290,866
U54 · FY2007 · AI · contact PI
Regulation and function of Pseudomonas drug efflux pumps$246,522
R01 · FY2006 · AI · contact PI
Burkholderia ssp. Novel Therapeutic Approaches$216,023
U54 · FY2006 · AI · contact PI
Non-antiobiotic resistance markers for bacteria$175,502
R21 · FY2006 · AI · contact PI
Regulation and function of Pseudomonas drug efflux pumps$252,454
R01 · FY2005 · AI
Burkholderia ssp. Novel Therapeutic Approaches$214,698
U54 · FY2005 · AI
Non-antiobiotic resistance markers for bacteria$179,725
R21 · FY2005 · AI
Genetic Tools for Pathogenic Bacteria$72,500
R03 · FY2005 · AI
Regulation and function of Pseudomonas drug efflux pumps$252,454
R01 · FY2004 · AI
Genetic Tools for Pathogenic Bacteria$72,500
R03 · FY2004 · AI
Regulation and function of Pseudomonas drug efflux pumps$277,454
R01 · FY2003 · AI
PSEUDOMONAS AUTOINDUCER BIOSYNTHESIS AND DRUG DISCOVERY$215,761
R01 · FY2001 · GM
PSEUDOMONAS AUTOINDUCER BIOSYNTHESIS AND DRUG DISCOVERY$210,725
R01 · FY2000 · GM